Saraf and Partners acted for Fortis Healthcare Limited in relation to the acquisition of 31.52% equity stake in its subsidiary, Agilus Diagnostics Limited, from three private equity investors, namely – NYLIM Jacob Ballas India Fund III LLC, Resurgence PE Investments Limited and IFC – International Finance Corporation for a cash consideration of approx. INR 1770 crores (approx. USD 207 million).
The transaction team was led by Senior Partner Vaibhav Kakkar, Partner Sahil Arora and Partner Debarpan Ghosh.
Source: Saraf & Partners’ LinkedIn Page
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
